Loading...
XTAE
TKUN
Market cap8mUSD
Dec 04, Last price  
33.30ILS
1D
-1.77%
1Q
-16.54%
Jan 2017
-99.25%
IPO
-99.95%
Name

Tikun Olam Cannbit Pharmaceuticals Ltd

Chart & Performance

D1W1MN
XTAE:TKUN chart
P/E
—
P/S
0.81
EPS
—
Div Yield, %
—
Shrs. gr., 5y
20.84%
Rev. gr., 5y
%
Revenues
35m
-20.97%
002,596,00000000021,659,00037,030,00049,297,00044,228,00034,952,000
Net income
-40m
L-54.88%
21,781,000-20,175,000-13,374,000-4,106,000-2,829,000-902,000-441,000-21,173,000-10,888,000-32,941,000-32,651,000-48,235,000-88,886,000-40,101,000
CFO
-4m
L+24.74%
-3,040,000-2,937,000-2,423,000-1,969,000-2,434,000-532,000-439,000-1,758,000-3,356,000-24,378,000-23,173,000-18,216,000-3,024,000-3,772,000
Dividend
Dec 28, 201128.2269 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the research, development, cultivation, manufacture, and distribution of medical cannabis and related products. It also provides training and patient care services. The company is based in Nof Hagalil, Israel.
URL
https://cannbit.com/
IPO date
Mar 01, 2000
Employees
102
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT